Company Filing History:
2 out of 55 
1 out of 613 
1 out of 2 Years Active: 1999-2002
Title: The Innovations of Choji Taya
Introduction
Choji Taya is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the study of hepatitis C. With a total of four patents to his name, Taya's work has been instrumental in advancing our understanding of this viral infection.
Latest Patents
Among his latest patents is the development of a hepatitis C animal model. This model incorporates cDNA derived from the hepatitis C virus, which is crucial for clarifying the onset mechanism of the disease and for developing treatment options. Another notable patent is the transgenic mouse hepatitis C virus model, which features a hepatitis C viral fragment. These transgenic mice serve as a valuable model for hepatitis C infection, showcasing various physiological changes upon administration of Cre, including increased serum GTP levels and alterations in liver cell structure.
Career Highlights
Throughout his career, Choji Taya has worked with esteemed organizations such as the Tokyo Metropolitan Institute of Medical Science and Sankyo Company, Limited. His research has significantly impacted the medical community's approach to hepatitis C, paving the way for future innovations in treatment and understanding of the virus.
Collaborations
Taya has collaborated with notable colleagues, including Hiromichi Yonekawa and Michinori Kohara. These partnerships have further enriched his research and contributed to the advancements in the field.
Conclusion
Choji Taya's innovative work in the realm of hepatitis C research exemplifies the importance of scientific inquiry and collaboration. His patents and career achievements highlight his dedication to improving medical science and patient outcomes.